Atlas Bio

See which development path to back before you commit.

Health and bio

Latest funding

$12.5M · October 27, 2026

Led by Creandum · Source: tech.eu

Total raised: $18.5M across 2 sourced rounds

All 2 rounds ↓

Website: atlas.bio.

LinkedIn: atlasbio.

Category: Health and bio.

Stage: Seed.

Total raised: $18.5M in 2 sourced rounds.

Last round: Oct 27, 2026 · 1 days ago.

On Recent Funding since: Oct 27, 2026.

Signals

Website registeredOct 17, 2023 (3 years old)

About Atlas Bio

Atlas runs in silico clinical trials in immunology using its foundation AI model of human biology to predict and compare patient responses across treatments and indications, helping biopharma teams decide what to advance, acquire or expand.

Funding rounds

October 27, 2026
Round · $12.5M
CCreandum (lead), LLEA Partners
Source: tech.eu
April 9, 2026
Seed · $6M
Source: fundraisingfox.com
October 17, 2023
Website created

Founders and team

SR
Simon Romanski Co-Founder & CEO

source: atlas.bio
SB
Sebastian Bayer Co-Founder & CTO

source: atlas.bio

Investors

Similar Health and bio companies

BBasalt Health$20M Series A · Oct 2026
CCent$15M Series A · Oct 2026
IImphatec$2M Seed · Oct 2026
Aadsilico$13.35M Series A · Oct 2026
CClinics On Cloud$12.61M Series A · Oct 2026
MMedikea$1.2M Pre Seed · Oct 2026

Other companies backed by Creandum

TTurba Labs$52M Series A · Oct 2026
JJack and Jill$40M Series A · Sep 2026
RRillet$100M Series B+ · Aug 2026
LLovable$400M Series B+ · Aug 2026
OOLIX$312M Series B+ · Aug 2026
PPassionfroot$15M Series A · Jul 2026

Creandum portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/atlas-bio (get a free API key).